# South Korea Infertility Market

> South Korea Infertility Market Research Report By Sex (Males, Females, Unexplained), By Diagnosis (Men Diagnostic Tests, Women Diagnostic Tests, General Diagnostic Test), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment, Others) and By Technology (Assisted Reproductive Technology, Intrauterine Insemination, Surgery) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.82%
- **2024:** $ 61.06 Million
- **2025:** $ 68.89 Million
- **2035:** $ 230.15 Million
- **Key Players:** CooperSurgical (US), Merck KGaA (DE), Ferring Pharmaceuticals (CH), Irvine Scientific (US), Vitrolife (SE), Reproductive Health Technologies (US), OvaScience (US), Genea (AU)

**Report ID:** MRFR/HC/43840-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-infertility-market-45520

---

## Market Summary

## **South Korea Infertility Market Overview**

As per MRFR analysis, the South Korea Infertility Market Size was estimated at 45.21 (USD Million) in 2024. The South Korea Infertility Market Industry is expected to grow from 51.0 (USD Million) in 2025 to 191.0 (USD Million) by 2035. The South Korea Infertility Market CAGR (growth rate) is expected to be around 12.754% during the forecast period (2025 - 2035).

## **Key South Korea Infertility Market Trends Highlighted**

In South Korea, the infertility market is witnessing significant shifts driven by several key market drivers. The increasing awareness about infertility issues among couples, along with a rising acceptance of assisted reproductive technologies, has contributed to the demand for fertility treatments.

As more South Koreans prioritize family planning, delayed marriages and later childbearing due to educational and career-focused pursuits are leading to higher infertility rates. Additionally, government initiatives supporting fertility treatments, including financial assistance for in vitro fertilization procedures, have further propelled the growth within this sector.

Recent trends show a growing interest in holistic and personalized fertility solutions that cater to individual needs. Many couples are seeking comprehensive fertility programs that incorporate lifestyle coaching and wellness resources, signifying a shift towards more integrated approaches in treatment.

Furthermore, advancements in medical technology, especially in vitro fertilization and pre-implantation genetic testing, are enhancing success rates and attracting more individuals to consider these options. Opportunities abound for stakeholders in the South Korean infertility market, particularly in the development of more affordable treatment plans and the expansion of telehealth services.

As the demand for fertility preservation rises, especially among younger women, there is a potential for fertility clinics to offer freezing and storage services. In addition, the recent focus on male infertility highlights an increasing acknowledgment of male health factors, expanding the landscape for tailored treatment solutions.

As these trends evolve, entities in the South Korean infertility market have ample avenues to explore, ensuring they meet the diverse needs of an evolving population.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **South Korea Infertility Market Drivers**

### **Rising Incidence of Infertility**

The South Korea Infertility Market Industry is significantly influenced by the rising incidence of infertility among couples. According to data from the Korean Society of Reproductive Medicine, approximately 15% of couples in South Korea face infertility issues, highlighting a growing need for assisted reproductive technologies and treatments.

As the societal focus shifts towards family planning and the increasing average age of marriage, women are prioritizing careers, which can lead to delays in childbearing. Furthermore, the Ministry of Health and Welfare in South Korea reports a growing trend towards in vitro fertilization (IVF) procedures, estimating an increase in such cases by over 30% between the years 2015 and 2020.

With the fertility rate in South Korea dropping to 0.81 children per woman in 2021, the demand for infertility solutions is poised to grow, thereby significantly contributing to the South Korea Infertility Market Industry's expansion.

### **Technological Advancements in Fertility Treatments**

Innovations in reproductive technology play a key role in propelling the South Korea Infertility Market Industry. The introduction of advanced techniques such as preimplantation genetic testing (PGT), egg freezing, and improved embryology methods have enhanced the outcomes of infertility treatments.

A report by the Korea Food and Drug Administration indicates a steady increase in the number of fertility clinics adopting these advanced technologies. Enhanced success rates, with reports indicating that PGT can improve the chances of successful pregnancies by over 50%, underscore the importance of such advancements in driving market growth.

### **Government Support and Policy Initiatives**

Government-backed initiatives are crucial for the growth of the South Korea Infertility Market Industry. The South Korean government has been actively promoting policies that support couples facing infertility challenges through financial assistance, awareness programs, and expanded health coverage.

Notably, the South Korean National Health Insurance Service has expanded its coverage to include fertility treatment, thus lowering the economic barriers for many couples. This shift has led to an estimated increase in the number of IVF cycles being funded by insurance exceeding 100,000 annually, reinforcing the accessibility of treatments.

As more couples are encouraged to seek treatment, the market is likely to experience substantial growth.

## **South Korea Infertility Market Segment Insights**

### **Infertility Market Sex Insights**

The South Korea Infertility Market has been increasingly recognized for its importance in addressing the growing concerns surrounding reproductive health, particularly in the context of sex as a dominant factor influencing fertility. With a considerable portion of the population seeking solutions for infertility, this segment showcases a diverse landscape.

This landscape is dominated by three key areas: males, females, and unexplained infertility cases. In recent years, South Korea has reported rising infertility rates, emphasizing the need for comprehensive treatment options tailored to specific demographic groups. This shift has been influenced by several factors, including lifestyle changes, delayed childbearing, and increasing awareness regarding reproductive health issues.

Males constitute a significant portion of the infertility discussions, often facing social stigmas that may deter them from seeking help or consulting medical professionals. Various factors such as environmental pollutants, sedentary lifestyles, and dietary habits have emerged as contributors to male infertility, highlighting the need for targeted interventions.

Accordingly, the healthcare sector is witnessing an increase in male fertility programs and educational initiatives aimed at debunking myths surrounding male reproductive health. Females represent another fundamental segment in the South Korea Infertility Market, largely influenced by social changes, the rising age of first-time mothers, and evolving career aspirations.

These trends have led to a greater focus on female reproductive health, increasing the demand for advanced reproductive technologies and comprehensive fertility treatments. Conditions such as polycystic ovary syndrome (PCOS) and endometriosis remain prevalent issues, necessitating the development of specialized medical approaches to address these challenges, thus providing opportunities for growth within this sector.

Moreover, unexplained infertility remains a critical area within the market as it often requires extensive testing and tailored treatment plans to address the various underlying factors contributing to a couple's difficulties in conceiving. This category presents unique challenges for both patients and healthcare providers, as the lack of an identifiable cause of infertility can lead to increased emotional stress among couples.

Hence, the demand for personalized healthcare solutions tailored to this segment is becoming more apparent. Overall, the South Korea Infertility Market offers a dynamic and multifaceted view of reproductive health, emphasizing the necessity for tailored approaches for males and females, as well as addressing unexplained infertility cases.

As the conversation surrounding fertility continues to evolve, stakeholders within this market are keen to understand the various facets that contribute to infertility challenges, ensuring that effective solutions are developed to meet the needs of the population.

The market growth across these areas indicates a promising future for the South Korean healthcare landscape as it adapts to the intricate demands of reproductive health and family planning. The increasing prevalence of infertility issues also paves the way for research and advancements in fertility treatments, thereby enhancing the overall South Korea Infertility Market statistics as a robust and vital industry.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Infertility Market Diagnosis Insights**

The Diagnosis segment of the South Korea Infertility Market plays a vital role in understanding and addressing fertility issues among couples. This segment encompasses a range of diagnostic tests, including Men's Diagnostic Tests, Women's Diagnostic Tests, and General Diagnostic Tests.

Men's Diagnostic Tests focus on assessing sperm quality, quantity, and motility, which are critical factors in male infertility and contribute significantly to overall fertility challenges faced by couples. Women’s Diagnostic Tests often include hormone level assessments, ovulation tracking, and imaging studies to evaluate reproductive health and ovarian reserve, making them crucial for effective fertility treatments.

General Diagnostic Tests provide an overarching view of both partners' fertility health, helping clinicians create tailored treatment plans. The growing emphasis on personalized healthcare in South Korea, alongside advancements in diagnostic technologies, continues to drive innovation in this segment.

Additionally, societal shifts, such as delayed parenthood and increased awareness of reproductive health issues, are contributing to heightened demand for these diagnostic services. The combination of these factors highlights the importance of accurate and comprehensive diagnostic testing in overcoming infertility challenges, thereby shaping the South Korea Infertility Market landscape.

### **Infertility Market Drugs Insights**

The South Korea Infertility Market, particularly in the Drugs segment, displays notable dynamics crucial for addressing reproductive challenges among individuals. Clomiphene Citrate has established itself as a leading choice for ovulation induction, emphasizing its role in assisting women undergoing fertility treatments.

Likewise, Letrozole has gained traction for its effectiveness, particularly in cases of polycystic ovary syndrome. Serophene also plays a significant role helping women to conceive by stimulating ovulation. Hormone treatments, vital in regulating endocrine functions, are integral to managing various infertility issues, ensuring that hormonal imbalances do not hinder conception efforts.

The emergence of alternative therapies under the 'Others' category reflects the growing inclination towards a diverse range of treatment options catering to specific patient needs. The South Korea Infertility Market statistics demonstrate a rising demand for these drugs, driven by factors such as increased awareness of infertility, supportive government policies, and advancements in reproductive technologies.

Market growth in this segment is further supported by the ongoing research focused on improving treatment efficacy and patient outcomes. Such developments underscore the importance of the Drugs segment in the broader context of South Korea's infertility treatment landscape.

### **Infertility Market Technology Insights**

The South Korea [Infertility Market](../../../reports/infertility-market-6145), particularly within the Technology segment, has been experiencing notable advancements driven by increasing awareness of reproductive health and technological innovations. Assisted Reproductive Technology (ART) has gained significant traction, as it offers couples facing infertility a viable path to conception through methods such as in vitro fertilization (IVF).

In particular, critiques of traditional treatments have led to a surge in preference for ART solutions, highlighting its efficacy. Intrauterine Insemination (IUI) also plays a crucial role, serving as a less invasive option to assist couples struggling to conceive, thereby broadening the accessibility of fertility treatments.

Furthermore, surgical interventions contribute to resolving anatomical issues that can hinder fertility, ensuring comprehensive care within this market. The integration of these technologies not only enhances treatment outcomes but also aligns with South Korea's efforts to address declining birth rates and improve reproductive health services, thus fostering a supportive environment for innovation in the infertility treatment sector.

The increasing investment in healthcare technology in South Korea amplifies the potential for growth in this market, presenting substantial opportunities for providers and stakeholders within the industry.

## **South Korea Infertility Market Key Players and Competitive Insights**

The South Korea Infertility Market is experiencing significant growth fueled by a combination of increasing awareness about reproductive health, advancements in medical technology, and a growing population of couples seeking fertility treatments.

As societal norms evolve and the stigma around infertility wanes, more individuals and couples are seeking help for fertility issues, contributing to a competitive landscape rich in innovation and diverse service offerings. The market features a blend of established players and emergent clinics, each vying to capture share through differentiated services, comprehensive treatment options, and patient-centered care.

The competitive insights within this market reflect a dynamic environment where quality, accessibility, and effective marketing strategies are critical to success. Hallym University Medical Center stands out in the South Korea Infertility Market with its strong reputation for delivering high-quality fertility treatments and specialized care.

Noted for its advanced reproductive technologies, the facility is committed to enhancing patient outcomes through personalized treatment plans tailored to individual needs. Hallym University Medical Center harnesses the expertise of seasoned reproductive endocrinologists and support staff, fostering a multidisciplinary approach that emphasizes both medical and emotional support.

The center's integration within the broader university health system augments its research capabilities, allowing it to remain at the forefront of innovative fertility solutions. This academic affiliation along with patient-centric practices positions Hallym University Medical Center as a formidable entity in this competitive landscape.

Asan Medical Center is also a key player in the South Korea Infertility Market, offering a comprehensive range of fertility services that include in-vitro fertilization, egg freezing, and genetic testing. Its reputation is built on advanced technologies and innovative treatment protocols that promise higher success rates for patients.

The center benefits from a robust infrastructure, allowing for thorough diagnostics and personalized treatment options tailored to the unique needs of each patient. Asan Medical Center has established itself as a leader in the market through strategic partnerships and potential mergers and acquisitions that enhance its capabilities and service offerings.

The commitment to research and development in reproductive medicine is a significant strength, bolstering its position in the market. A strong focus on accessibility and a patient-friendly approach ensures that Asan Medical Center continues to attract a diverse patient base, solidifying its status in the competitive South Korean infertility sector.

### **Key Companies in the South Korea Infertility Market Include**

- Hallym University Medical Center
- [Asan Medical Center](https://eng.amc.seoul.kr/gb/lang/specialities/illness.do?parentId=18)
- Korea Institute of Science and Technology
- Medytox
- Severance Hospital
- Korea Hospital Association
- Green Cross Holdings
- CHA Biotech
- Sooam Biotech Research Foundation
- Yonsei University Health System
- Korea University Medical Center
- Gachon University Gil Medical Center
- Samsung Medical Center
- Reproductive Health Science

### **South Korea Infertility Market Industry Developments**

Recent developments in the South Korea Infertility Market have highlighted the increasing focus on advanced reproductive technologies and healthcare services. Hallym University Medical Center and Asan Medical Center are expanding their fertility programs amid rising demand for assisted reproductive technologies in the nation.

The Korea Institute of Science and Technology is advancing research on reproductive medicine, enhancing the potential for innovative treatments. Notable growth in the market valuation of companies like CHA Biotech and Medytox has positively influenced investment in fertility services.

In April 2023, Gachon University Gil Medical Center reported an expansion of its reproductive health initiatives, which has garnered attention. Korea University Medical Center has also made strides in integrating state-of-the-art techniques into their IVF programs over the past two years.

Noteworthy partnerships among healthcare institutions, including collaboration with the Korea Hospital Association, aim to improve the quality of fertility care across the board. Additionally, ongoing research initiatives by Sooam Biotech Research Foundation and Yonsei University Health System indicate a progressive shift towards overcoming infertility challenges in South Korea.

## **South Korea Infertility Market Segmentation Insights**

### **Infertility Market Sex Outlook**

- Males
- Females
- Unexplained

### **Infertility Market Diagnosis Outlook**

- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

### **Infertility Market Drugs Outlook**

- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

### **Infertility Market Technology Outlook**

- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

## Market Drivers

### Rising Infertility Rates

The infertility market in South Korea is experiencing growth due to increasing infertility rates among couples. Recent statistics indicate that approximately 15% of couples in South Korea face infertility issues, a figure that has been steadily rising. Factors contributing to this trend include delayed marriages, lifestyle changes, and environmental influences. As more couples seek assistance, the demand for infertility treatments and services is likely to increase. This trend suggests a robust market potential for clinics and healthcare providers specializing in reproductive health. The rising infertility rates are prompting a greater focus on innovative treatment options, thereby driving the overall growth of the infertility market.

### Government Policies and Funding

Government initiatives aimed at addressing infertility issues are playing a pivotal role in shaping the infertility market in South Korea. Policies that provide financial support for fertility treatments, such as subsidies and insurance coverage, are encouraging more couples to pursue assistance. Recent reports indicate that government funding for infertility treatments has increased, making these services more accessible. This support not only alleviates the financial burden on couples but also promotes a culture of seeking help for infertility. The proactive stance of the government is likely to stimulate growth in the infertility market by increasing the number of individuals seeking treatment.

### Increased Awareness and Education

There is a growing awareness regarding infertility issues in South Korea, which is significantly impacting the infertility market. Educational campaigns and media coverage have played a crucial role in informing the public about reproductive health and available treatment options. As awareness increases, more individuals and couples are likely to seek medical advice and treatment for infertility. This shift in perception is expected to lead to a higher demand for fertility services, including in vitro fertilization (IVF) and other assisted reproductive technologies. The increased focus on education and awareness is likely to enhance the overall growth trajectory of the infertility market.

### Cultural Shifts and Family Planning

Cultural attitudes towards family planning and childbearing are evolving in South Korea, influencing the infertility market. Traditionally, there has been a strong emphasis on early marriage and childbearing; however, contemporary societal norms are shifting towards later family planning. This change is leading to a rise in infertility cases as couples delay starting families. As societal acceptance of infertility treatments grows, more individuals are likely to seek assistance. This cultural shift is expected to drive demand for fertility services, thereby contributing to the expansion of the infertility market in the coming years.

### Advancements in Reproductive Technologies

Technological innovations in reproductive health are transforming the infertility market in South Korea. The introduction of advanced techniques such as preimplantation genetic testing (PGT) and cryopreservation has improved success rates for fertility treatments. These advancements not only enhance the effectiveness of treatments but also provide patients with more options tailored to their specific needs. As technology continues to evolve, it is anticipated that the market will see an influx of new services and products aimed at improving fertility outcomes. The ongoing research and development in reproductive technologies are likely to be a key driver of growth in the infertility market.

## Future Outlook

The [Infertility Market](https://www.marketresearchfuture.com/reports/infertility-market-6145) in South Korea is projected to grow at a 12.82% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising infertility rates.

**New opportunities:**

- Development of AI-driven fertility tracking applications
- Expansion of telehealth services for remote consultations
- Investment in advanced reproductive technologies like CRISPR

By 2035, the infertility market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Assisted Reproductive Technology (Largest) vs. Hormone Therapy (Fastest-Growing)

In the South Korea infertility market, the Assisted Reproductive Technology (ART) segment commands the largest share, reflecting its prominence in addressing infertility challenges. This segment encompasses a range of treatments, ensuring that couples have access to cutting-edge solutions tailored to their needs. Following closely, Hormone Therapy is rapidly gaining traction, appealing to those seeking non-invasive alternatives to traditional ART. This distribution highlights a dynamic landscape where ART remains dominant while Hormone Therapy emerges as a preferred choice for many couples experiencing hormonal imbalances.

Growth trends in the South Korea infertility market are driven by increasing awareness of fertility issues and advancements in medical technologies. The ART segment benefits from significant investments and continuous innovations that improve success rates and reduce the emotional burden on patients. On the other hand, Hormone Therapy's appeal lies in its non-invasive nature, making it increasingly popular among younger demographics. This evolving landscape showcases a growing acceptance of various treatment options, fueled by changing societal attitudes towards fertility and family planning.

Assisted Reproductive Technology (Dominant) vs. Hormone Therapy (Emerging)

Assisted Reproductive Technology (ART) has established itself as the dominant force within the South Korea infertility market, characterized by a comprehensive array of procedures including in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Its extensive integration into infertility treatments, backed by robust clinical outcomes, allows it to cater to a wide spectrum of patients. Conversely, Hormone Therapy is emerging as a significant alternative, particularly for those who prefer less invasive methods. This segment focuses on regulating hormonal imbalances and improving fertility through medication, appealing to a demographic that values medical personalization and ease of access. As healthcare providers enhance their offerings in both segments, the competition will likely spur further innovations, benefitting prospective parents.

### By End User: Hospitals (Largest) vs. Fertility Clinics (Fastest-Growing)

In the South Korea infertility market, the distribution of market share among end users reveals that hospitals currently hold a significant portion of the market due to their comprehensive services and resources. Fertility clinics, while smaller in share, are gaining traction as they offer specialized care tailored to individual needs, translating to rapid growth and increased patient engagement.

The growth trends for these segments are influenced by various factors, including the rising awareness of infertility issues and the increasing willingness of couples to seek treatments. Fertility clinics are expected to continue their upward trajectory, driven by advancements in reproductive technologies and personalized treatment plans, while hospitals remain essential for advanced procedures and surgical interventions.

Hospitals: Dominant vs. Fertility Clinics: Emerging

Hospitals play a dominant role in the South Korea infertility market, primarily due to their extensive capabilities and the integration of various healthcare services under one roof. They offer a wide range of reproductive health services, including surgical procedures, counseling, and diagnostic screenings, making them a reliable choice for patients. On the other hand, fertility clinics are emerging as a vital alternative, increasingly preferred for their personalized approach to infertility treatments. These clinics often provide specialized services, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), which cater to the unique needs of patients. With a focus on innovation and patient-centered care, fertility clinics attract a growing number of clients who seek targeted solutions for infertility.

### By Gender: Female (Largest) vs. Male (Fastest-Growing)

In the South Korea infertility market, the distribution of market share between female and male segments reveals that female-oriented treatments and services dominate the landscape. This dominance can largely be attributed to the higher prevalence of infertility challenges among women, hence leading to a greater demand for female-focused infertility solutions. The focus on female infertility often results in a more established market presence for such treatments, facilitating a significant share of the overall market.

Female (Dominant) vs. Male (Emerging)

Female treatments in the South Korea infertility market are characterized by a wide array of services, including ovarian stimulation, intrauterine insemination (IUI), and in vitro fertilization (IVF). These services cater predominantly to the growing awareness and prevalence of infertility issues among women. Meanwhile, the male segment is emerging rapidly, driven by increasing recognition of male infertility factors and the expansion of male-oriented treatments such as sperm retrieval and assisted reproductive technologies. The shift towards recognizing male contributions to infertility has spurred innovation and growth in their market segment, positioning it as a significant area of development in the fertility treatment arena.

### By Cause of Infertility: Ovulatory Disorders (Largest) vs. Male Factor Infertility (Fastest-Growing)

In the South Korea infertility market, Ovulatory Disorders hold a dominant market share, attributed to the increasing prevalence of hormonal imbalances among women. This segment is often linked to a variety of health issues including PCOS and thyroid abnormalities, which are becoming more common in recent years. In contrast, Male Factor Infertility is emerging as a significant player, reflecting a shift in awareness and diagnosis of male infertility issues, particularly due to lifestyle factors that affect sperm quality and count.

The growth trends in the South Korea infertility market indicate a rising demand for assisted reproductive technology (ART) services, fostering advancements in treatments for both Ovulatory Disorders and Male Factor Infertility. The increasing number of couples seeking help for infertility is fueled by social changes, including delayed childbearing and higher stress levels. Additionally, educational efforts aimed at improving awareness about male infertility are promoting earlier interventions and treatment options, thus contributing to the rapid growth of this segment.

Ovulatory Disorders (Dominant) vs. Male Factor Infertility (Emerging)

Ovulatory Disorders are characterized by irregular ovulation, leading to fertility challenges for many women. This segment benefits from advanced diagnostic tools and treatment options such as hormonal therapies and in vitro fertilization (IVF), which are well-established in the South Korea infertility market. On the other hand, Male Factor Infertility is gaining attention as a critical area of focus in fertility treatments, often involving assessments of sperm health and motility. This emerging segment is responding to lifestyle changes, with more men recognizing factors like diet, smoking, and environmental impacts on fertility. Both segments represent crucial aspects of the infertility landscape, shaping treatment protocols and patient outreach strategies.

## Competitive Benchmarking

The infertility market in South Korea is characterized by a dynamic competitive landscape, driven by increasing awareness of reproductive health and advancements in assisted reproductive technologies (ART). Key players such as CooperSurgical (US), Merck KGaA (DE), and Ferring Pharmaceuticals (CH) are strategically positioned to leverage innovation and partnerships to enhance their market presence. CooperSurgical (US) focuses on expanding its product portfolio through acquisitions, while Merck KGaA (DE) emphasizes research and development to introduce cutting-edge solutions. Ferring Pharmaceuticals (CH) is actively pursuing collaborations with local healthcare providers to improve service delivery, thereby shaping a competitive environment that prioritizes innovation and accessibility.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive technological advancements and set industry standards, thereby shaping the overall competitive dynamics.
In October 2025, Merck KGaA (DE) announced a strategic partnership with a leading South Korean fertility clinic to co-develop personalized treatment protocols. This collaboration is expected to enhance patient outcomes by integrating advanced analytics into treatment plans, reflecting a growing trend towards personalized medicine in the infertility sector. The strategic importance of this partnership lies in its potential to position Merck KGaA (DE) as a leader in tailored reproductive solutions, thereby enhancing its competitive edge.
In September 2025, Ferring Pharmaceuticals (CH) launched a new fertility medication aimed at improving success rates in IVF procedures. This product introduction is significant as it addresses a critical need in the market, potentially increasing Ferring's market share. The launch underscores the company's commitment to innovation and its ability to respond to evolving patient needs, which is crucial in a competitive landscape.
In November 2025, CooperSurgical (US) expanded its operations in South Korea by establishing a new manufacturing facility dedicated to reproductive health products. This move is strategically important as it not only enhances local production capabilities but also reduces lead times for product availability. By investing in local infrastructure, CooperSurgical (US) demonstrates its commitment to the South Korean market and its intent to strengthen its competitive position through improved supply chain reliability.
As of November 2025, current trends in the infertility market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative treatment solutions, and reliable supply chains. This shift indicates a growing recognition that long-term success in the infertility market will depend on the ability to deliver superior value through innovation and enhanced patient care.

## Recent News & Developments

Recent developments in the South Korea Infertility Market have highlighted the increasing focus on advanced reproductive technologies and healthcare services. Hallym University Medical Center and Asan Medical Center are expanding their fertility programs amid rising demand for assisted reproductive technologies in the nation.

The Korea Institute of Science and Technology is advancing research on reproductive medicine, enhancing the potential for innovative treatments. Notable growth in the market valuation of companies like CHA Biotech and Medytox has positively influenced investment in fertility services.

In April 2023, Gachon University Gil Medical Center reported an expansion of its reproductive health initiatives, which has garnered attention. Korea University Medical Center has also made strides in integrating state-of-the-art techniques into their IVF programs over the past two years.

Noteworthy partnerships among healthcare institutions, including collaboration with the Korea Hospital Association, aim to improve the quality of fertility care across the board. Additionally, ongoing research initiatives by Sooam Biotech Research Foundation and Yonsei University Health System indicate a progressive shift towards overcoming infertility challenges in South Korea.

## Report Scope

| MARKET SIZE 2024 | 61.06(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 68.89(USD Million) |
| MARKET SIZE 2035 | 230.15(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.82% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | CooperSurgical (US), Merck KGaA (DE), Ferring Pharmaceuticals (CH), Irvine Scientific (US), Vitrolife (SE), Reproductive Health Technologies (US), OvaScience (US), Genea (AU) |
| Segments Covered | Type, End User, Gender, Cause of Infertility |
| Key Market Opportunities | Emergence of advanced reproductive technologies and increasing awareness drive growth in the infertility market. |
| Key Market Dynamics | Rising demand for advanced reproductive technologies drives innovation and competition in the infertility market. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the overall market valuation of the South Korea infertility market in 2024?**
A: The overall market valuation was $61.06 Million in 2024.

**Q: What is the projected market valuation for the South Korea infertility market by 2035?**
A: The projected market valuation for 2035 is $230.15 Million.

**Q: What is the expected CAGR for the South Korea infertility market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 12.82%.

**Q: Which segments contributed to the South Korea infertility market in terms of type?**
A: The segments include Assisted Reproductive Technology, Hormone Therapy, Surgery, and Fertility Preservation.

**Q: What were the valuations for Assisted Reproductive Technology in 2024?**
A: The valuation for Assisted Reproductive Technology ranged from $20.0 Million to $80.0 Million.

**Q: How do hospitals and fertility clinics compare in terms of market valuation?**
A: In 2024, hospitals had a valuation of $20.42 Million to $78.06 Million, while fertility clinics ranged from $25.53 Million to $98.07 Million.

**Q: What is the gender distribution in the South Korea infertility market?**
A: The market shows equal valuations for both genders, with each ranging from $30.53 Million to $115.08 Million for females and $30.53 Million to $115.07 Million for males.

**Q: What are the primary causes of infertility addressed in the South Korea market?**
A: Primary causes include Ovulatory Disorders, Uterine or Cervical Abnormalities, Tubal Factors, and Male Factor Infertility.

**Q: What was the valuation for Male Factor Infertility in 2024?**
A: The valuation for Male Factor Infertility ranged from $24.06 Million to $90.15 Million.

**Q: Who are the key players in the South Korea infertility market?**
A: Key players include CooperSurgical, Merck KGaA, Ferring Pharmaceuticals, Irvine Scientific, Vitrolife, Reproductive Health Technologies, OvaScience, and Genea.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-infertility-market-45520*